Dosing Recommendations for Quetiapine When Coadministered With HIV Protease Inhibitors.

Autor: Sampson MR; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Review, Food and Drug Administration, Silver Spring, MD, USA., Cao KY; Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Gish PL; Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Hyon K; Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Mishra P; Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Tauber W; Division of Antiviral Products, Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Zhao P; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Review, Food and Drug Administration, Silver Spring, MD, USA., Zhou EH; Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Younis IR; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Review, Food and Drug Administration, Silver Spring, MD, USA.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2019 Apr; Vol. 59 (4), pp. 500-509. Date of Electronic Publication: 2018 Nov 19.